Vivimed Labs Ltd Q4FY22 consolidated loss at Rs. 18.33 crores

Vivimed Labs Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 61.7027 crores during the period ended March 31, 2022 as compared to Rs. 56.1612 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. -18.3335 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -23.6821 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. -2.15 for the period ended March 31, 2022 as compared to Rs. -2.77 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 61.7027 crs	₹56.1612 crs	9.87%
Net Profit	₹ -18.3335 crs	₹-23.6821 crs	22.58%
EPS	₹-2.15	₹-2.77	22.38%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 61.7027 crores during the period ended March 31, 2022 as compared to Rs.40.7753 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs. -18.3335 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-27.4640 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.-2.15 for the period ended March 31, 2022 as compared to Rs.-3.22 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 61.7027 crs	₹40.7753 crs	51.32%
Net Profit	₹ -18.3335 crs	₹-27.4640 crs	33.25%
EPS	₹-2.15	₹-3.22	33.23%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.238.5567 crores during the Financial Year ended March 31, 2022 as compared to Rs.871.2906 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.-67.6502 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-77.7950 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.-7.92 for the Financial Year ended March 31, 2022 as compared to Rs.-9.11 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹238.5567 crs	₹871.2906 crs	-72.62%
Net Profit	₹-67.6502 crs	₹-77.7950 crs	13.04%
EPS	₹-7.92	₹-9.11	13.06%

Shares of Vivimed Labs Limited was last trading in BSE at Rs. 13.33 as compared to the previous close of Rs. 13.27. The total number of shares traded during the day was 11411 in over 218 trades.

The stock hit an intraday high of Rs. 13.45 and intraday low of 13.23. The net turnover during the day was Rs. 152093.00.

Source : Equity Bulls

Keywords

VivimedLabs Q4FY22 FY2022 ResultUpdate